Ruth Franken

Ruth Franken

Senior Associate, Amsterdam

Email ruth.franken@​hoganlovells.com

Phone +31 20 55 33 738

Fax +31 20 55 33 777

LanguagesEnglish, Dutch

Practice groupRegulatory

Highly skilled and experienced team acting on both domestic and international matters. Regularly represents pharmaceutical organisations in all aspects of creating and releasing a product.

Chamber 2015

As a senior associate, Ruth Franken focuses on the EU and Dutch Life Sciences industry (medicinal products, medical devices and food). She has extensive experience in advising pharmaceutical companies on EU and Dutch regulatory matters, e.g. how to obtain market access through marketing authorisation procedures (general requirements, clinical trials, regulatory data protection and exclusivity rights, etc.), pricing and reimbursement (procedures, financial arrangements) and how to be compliant in a fast moving and changing environment (interactions with healthcare professionals, compliance issues, audits, legal procedures, etc.).

Ruth regularly publishes newsletters on European and Dutch Life Sciences developments and contributes to a number of international Life Sciences publications, e.g. the Oxford Handbook on 'Drafting agreements in the biotechnology and pharmaceutical industries', Chambers legal practice guide Life Sciences the Commercialisation of Healthcare and Getting the deal through. She obtained her law degree from Radboud University Nijmegen. Before joining Hogan Lovells in July 2011, Ruth worked as a lawyer with a Dutch law firm since 2007.

Education and admissions

Education

Master of Laws, Radboud University Nijmegen, 2006

Memberships

Dutch Association for Pharmacy and Law

Dutch Food Law Association

Representative experience

Advising various national and international pharmaceutical companies in respect of reimbursement and additional financing for expensive medicinal products.

Advising and negotiating a various number of pharmaceutical agreements, such as agreements regarding the management and conduct of clinical trials and distribution agreements.

Advising on reimbursement policies and strategies of Dutch healthcare insurance companies for both medicinal products as well as medical devices.

Advising on the requirements for named patient and compassionate use programs in the Netherlands and other EU member states.

Advising an various issues regarding distribution, import and export of medicinal products.

Ruth contributed to the Oxford Handbook on 'Drafting agreements in the biotechnology and pharmaceutical industries' regarding Dutch law aspects.

Ruth was seconded for over a year on a part time basis to an international pharmaceutical company as legal counsel.

Loading data